Dr. Ramey D. Littell
Claim this profileKaiser Permanente-Roseville
Studies Ovarian Cancer
Studies Adenocarcinoma
5 reported clinical trials
13 drugs studied
Area of expertise
1Ovarian Cancer
BRCA1 positive
Stage II
Stage III
2Adenocarcinoma
Stage III
Stage IV
Stage II
Affiliated Hospitals
Clinical Trials Ramey D. Littell is currently running
Letrozole +/- Chemotherapy
for Ovarian Cancer
This phase III trial studies how well letrozole with or without paclitaxel and carboplatin works in treating patients with stage II-IV low-grade serous carcinoma of the ovary, fallopian tube, or peritoneum. Letrozole is an enzyme inhibitor that lowers the amount of estrogen made by the body which in turn may stop the growth of tumor cells that need estrogen to grow. Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether giving letrozole alone or in combination with paclitaxel and carboplatin works better in treating patients with low-grade serous carcinoma of the ovary, fallopian tube, or peritoneum compared to paclitaxel and carboplatin without letrozole.
Recruiting2 awards Phase 318 criteria
Surgical Procedures
for Reducing Ovarian Cancer Risk
This study evaluates how well two surgical procedures (bilateral salpingectomy and bilateral salpingo-oophorectomy) work in reducing the risk of ovarian cancer for individuals with BRCA1 mutations. Bilateral salpingectomy involves the surgical removal of fallopian tubes, and bilateral salpingo-oophorectomy involves the surgical removal of both the fallopian tubes and ovaries. This study may help doctors determine if the two surgical procedures are nearly the same for ovarian cancer risk reduction for women with BRCA1 mutations.
Recruiting1 award N/A
More about Ramey D. Littell
Clinical Trial Related4 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Ramey D. Littell has experience with
- Paclitaxel
- Letrozole
- Paclitaxel, Carboplatin
- Bilateral Salpingectomy With Oophorectomy
- Bilateral Salpingectomy
- Atezolizumab
Breakdown of trials Ramey D. Littell has run
Ovarian Cancer
Adenocarcinoma
Fallopian Tube Cancer
Ovarian Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ramey D. Littell specialize in?
Ramey D. Littell focuses on Ovarian Cancer and Adenocarcinoma. In particular, much of their work with Ovarian Cancer has involved BRCA1 positive patients, or patients who are Stage II.
Is Ramey D. Littell currently recruiting for clinical trials?
Yes, Ramey D. Littell is currently recruiting for 2 clinical trials in Roseville California. If you're interested in participating, you should apply.
Are there any treatments that Ramey D. Littell has studied deeply?
Yes, Ramey D. Littell has studied treatments such as Paclitaxel, Letrozole, Paclitaxel, Carboplatin.
What is the best way to schedule an appointment with Ramey D. Littell?
Apply for one of the trials that Ramey D. Littell is conducting.
What is the office address of Ramey D. Littell?
The office of Ramey D. Littell is located at: Kaiser Permanente-Roseville, Roseville, California 95661 United States. This is the address for their practice at the Kaiser Permanente-Roseville.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.